Demographics (2)
- Age - Age at registration (phv00436457.v1.p1)
- SEX - Gender of participant (phv00436452.v1.p1)
Race and Ethnicity (2)
- Ethnicity - Ethnicity of participant (phv00436455.v1.p1)
- Race - Race of participant (phv00436454.v1.p1)
Other (30)
- adj.PN2cmds - Cumulative doses (adjused by BSA) at the first instace of grade 2 or higher peripheral neuropathy event (phv00436458.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00436475.v1.p1)
- anyvisceral - Site of metastases in any visceral (phv00436464.v1.p1)
- Arm - Treatment arm (phv00436453.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00436474.v1.p1)
- CONSENT - Consented group for genetic studies (phv00436448.v1.p1)
- dfi01 - Disease free interval above 2 years (phv00436465.v1.p1)
- ETA1 - Estimated between-subject variability of a baseline of CIPN score (phv00436468.v1.p1)
- ETA2 - Estimated between-subject variability of a slope between CIPN score and a virtual infusion rate (phv00436469.v1.p1)
- ETA3 - Estimated between-subject variability of a zero-order rate constant for the appearance of CIPN symptoms (phv00436470.v1.p1)
- ETA4 - Estimated between-subject variability of an elimination rate constant from the virtual drug exposure compartment (phv00436471.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00436479.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00436476.v1.p1)
- IS_TUMOR - Tumor status (phv00436477.v1.p1)
- PFS_ana_sample - Indicator for samples in PFS analytical cohort (phv00436466.v1.p1)
- PFS_val_sample - Indicator for samples in PFS validation cohort (phv00436467.v1.p1)
- pfsmos - Months of progression free survival (phv00436462.v1.p1)
- pfsstat - Progress free survival status (phv00436463.v1.p1)
- PLATE_ID - Sample plate and well number (phv00436478.v1.p1)
- PN_prog_sample - Indicator for samples in PN disease progression analysis (phv00436472.v1.p1)
- pn2plus_event - Indicator for samples with reported grade 2 or higher peripheral neuropathy event (phv00436456.v1.p1)
- PNsample - Indicator for samples in PN study (phv00436459.v1.p1)
- priortax - Prior taxane therapy (phv00436460.v1.p1)
- receptor - ER or PgR Positive (phv00436461.v1.p1)
- SAMPLE_ID - Sample ID (phv00436473.v1.p1)
- SAMPLE_ID - Sample ID (phv00436450.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00436480.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00436451.v1.p1)
- SUBJECT_ID - Subject ID (phv00436447.v1.p1)
- SUBJECT_ID - Subject ID (phv00436449.v1.p1)